Celsius Holdings, Inc. (NASDAQ:CELH) Shares Purchased by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund raised its stake in Celsius Holdings, Inc. (NASDAQ:CELH) by 200.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,790 shares of the company’s stock after purchasing an additional 15,860 shares during the period. Illinois Municipal Retirement Fund’s holdings in Celsius were worth $1,297,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CELH. Allspring Global Investments Holdings LLC raised its stake in Celsius by 633.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,422,367 shares of the company’s stock worth $77,547,000 after acquiring an additional 1,228,560 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Celsius by 18.7% during the third quarter. Vanguard Group Inc. now owns 4,846,599 shares of the company’s stock worth $831,676,000 after purchasing an additional 762,087 shares in the last quarter. Braun Stacey Associates Inc. lifted its holdings in shares of Celsius by 192.5% in the 3rd quarter. Braun Stacey Associates Inc. now owns 634,863 shares of the company’s stock valued at $108,942,000 after purchasing an additional 417,825 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in shares of Celsius in the 4th quarter valued at about $18,676,000. Finally, Lord Abbett & CO. LLC purchased a new position in Celsius during the 3rd quarter worth approximately $37,873,000. Institutional investors and hedge funds own 60.95% of the company’s stock.

Insiders Place Their Bets

In other news, major shareholder Deborah Desantis sold 127,838 shares of Celsius stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $42.90, for a total transaction of $5,484,250.20. Following the completion of the sale, the insider now directly owns 30,576,919 shares in the company, valued at approximately $1,311,749,825.10. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Celsius news, CFO Jarrod Langhans sold 4,079 shares of the firm’s stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $69.42, for a total transaction of $283,164.18. Following the completion of the transaction, the chief financial officer now directly owns 83,670 shares in the company, valued at approximately $5,808,371.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Deborah Desantis sold 127,838 shares of the company’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $42.90, for a total transaction of $5,484,250.20. Following the completion of the sale, the insider now directly owns 30,576,919 shares in the company, valued at approximately $1,311,749,825.10. The disclosure for this sale can be found here. Over the last three months, insiders have sold 652,319 shares of company stock worth $43,575,475. 2.20% of the stock is owned by company insiders.

Celsius Price Performance

Shares of CELH stock opened at $73.16 on Friday. The business’s fifty day moving average price is $79.78 and its 200 day moving average price is $64.88. The firm has a market capitalization of $16.90 billion, a PE ratio of 94.61, a P/E/G ratio of 2.09 and a beta of 1.86. Celsius Holdings, Inc. has a 1-year low of $29.92 and a 1-year high of $99.62.

Celsius (NASDAQ:CELH) last posted its quarterly earnings results on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The business had revenue of $347.44 million for the quarter, compared to analysts’ expectations of $326.77 million. During the same period in the prior year, the company posted $0.01 EPS. The business’s revenue for the quarter was up 95.2% on a year-over-year basis. Equities research analysts expect that Celsius Holdings, Inc. will post 1.09 earnings per share for the current fiscal year.

Analyst Ratings Changes

CELH has been the subject of several research analyst reports. Jefferies Financial Group increased their price objective on Celsius from $98.00 to $105.00 and gave the company a “buy” rating in a report on Monday, March 18th. Roth Mkm increased their price target on shares of Celsius from $90.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, March 14th. UBS Group lifted their price objective on shares of Celsius from $73.00 to $99.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Stifel Europe increased their target price on shares of Celsius from $90.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, March 18th. Finally, Stifel Nicolaus raised their price target on Celsius from $67.00 to $90.00 and gave the stock a “buy” rating in a report on Friday, March 1st. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $85.10.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.